ELSEVIRE Global Medical News
Search Elsevier Global Medical News
Clinical Neurology News
 
 
  Diamond Headache   American Academy of Neurology   American Headache Society
 
This news site is not sanctioned by, nor part of, the Diamond Headache Foundation, The American Academy of Neurology OR The American Headache Society.
News covering selected sessions related to migraine from 2008 medical conferences.
Diamond Headache Clinic Research and Educational Foundation Annual Research Summit Scottsdale, Arizona February 18-22, 2008
 
 
  Gender Based issues in Epilepsy Management
 
  Migraine Preventative therapies
 
  Distinquising Between Migraine and Tension Headache
 
Perimenopuasl Issues and Migraine
 
  Migraine Headache-Diagnosis and Treatment
 
  Biology of Migraine and other Headaches
 
  Exertional Headache: Uncommon, Usually Benign,
but Worrisome
 
  Vertigo, Dizziness Often Reported With Migraine, but Are They Related?
 
  Central Sensitization and Cutaneous Allodynia Implication on Migraine Treatment
 
  Expect the Unexpected When Headache Occurs in Older Patients
 
  Often Implicated, the Eye Rarely Causes Headache
 
Defining the Complicated Migraine
 
Studies Reveal Migraine with Aura is a Risk Factor for Heart Disease
 
Hormonal Therapies for Migraine: Risks vs Benefits
 
Menstrual Migraines
 
Cluster Headache
 
Emergency Department Treatment of Headache
 
 
  Often Implicated, the Eye Rarely Causes Headache  
BY DON SCHRADER
Contributing Writer
SCOTTSDALE, ARIZ. (ECCC)— Despite multiple associations with headache, the eye rarely causes headache or other types of pain, said Dr. Robert B. Daroff on February 21 at a headache course sponsored by the Diamond Headache Clinic Research and Education Foundation.
“Many primary care physicians think the eye is a major cause of headache,” said Dr. Daroff, professor of neurology at Case Western Reserve University and University Hospitals in Cleveland. “There seems to be almost a reflex response to send patients to the ophthalmologist, even though eye disease is a very infrequent cause of monosymptomatic eye or head pain.”
Dr. Daroff defined monosymptomatic eye pain as a normal-appearing and normal-functioning eye, with pain as the only symptom. Conditions that cause such pain are relatively few and extremely rare. Pain arises from what ophthalmologists call a “red eye.” A normal-appearing “white eye” usually is just that: normal. Non-ophthalmologists are unlikely to see patients with these conditions.
“If the gonioscopy is normal, look behind the eye for the cause of a monosymptomatic painful white eye,” said Dr. Daroff.
The widespread belief that the eye is a common cause of headache is understandable, given the multiple associations between the eye and headache:
• Certain types of eye disease may cause headache.
• The eye and periocular area are often the epicenter of pain in primary headaches, such as migraine, tension-type, and cluster headache.
• Photophobia frequently occurs concomitantly with primary and secondary headaches.
• Primary and secondary headache syndromes often have ophthalmic manifestations, and ocular disorders can arise secondarily to treatment for migraine.

Among non-ocular causes of eye pain, headache ranks at or near the top, according to Dr. Daroff. Migraine, cluster headache, and tension-type headache all can have eye pain as part of the symptom constellation. However, a multitude of other conditions also can cause eye pain, including ophthalmic division trigeminal neuralgia, herpes zoster, sinusitis, and dental abscess.
Photophobia can occur with any type of headache that involves the front of the head. The differential workup for a patient with headache and photophobia is the same as for a patient with headache alone, explained Dr. Daroff.
In addition to photophobia, phonophobia and osmophobia (or olfactophobia) are not uncommon among migraine patients.
“It seems that migraine patients have a lower sensory threshold,” said Dr. Daroff. “These sensory sensitivities can occur during migraine, or they can induce headache.”
Migraine with aura represents another link between headache and the eye. More than 90% of migraine auras are visual and involve homonymous positive visual phenomena, such as scintillations, bright spots, and zig-zag lines. Though typically hemifield or quadrant in localization, the visual aura can expand and ultimately involve the entire visual field, according to Dr. Daroff.
Migrainous vertigo has presented a challenge to the International Headache Society’s (IHS) classification system. When vertigo precedes or accompanies migraine, the eye movement should be regarded as an aura. However, the aura would be atypical because the IHS headache classification system defines a “typical” aura as being somatosensory, visual, or aphasic. The IHS system does not have a category of migraine with atypical aura, Dr. Daroff noted.
Migraine-associated vertigo does not respond to the medications commonly used to treat migraine. Some headache specialists believe vertigo will respond to prophylactic treatments for migraine, but the scientific proof is lacking, said Dr. Daroff.
Still another association between headache and the eyes comes in the form of ophthalmoplegic migraine. The condition typically has onset during childhood and involves the third cranial nerve, or less frequently, the fourth or sixth nerve. The headache usually lasts for several days, and migraine-associated symptoms are uncommon. As the headache resolves, diplopia begins and may progress and persist for weeks after the headache has resolved.
The ophthalmoplegic migraine is rare, particularly in adults, said Dr. Daroff. An MRI scan of patients with the condition may exhibit contrast enhancement and thickening of the subarachnoid portion of the nerve. However, the imaging abnormality may not appear until after a patient has had several episodes of ophthalmoplegic migraine, Dr. Daroff pointed out.
Copyright 2008 Elsevier Custom Conference Coverage. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the copyright owner. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made. Opinions expressed in this publication are those of the original authors and do not necessarily reflect those of the Publisher, the sponsor, or the editors. Elsevier assumes no liability for any material published herein.
 

Terms of Use                                    Privacy Policy                                    Contact Us

 
  Copyright ©2010 Elsevier/International Medical News Group
  5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Rights reserved Clinical Neurology News Network